SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,764.23 -813.35
( -1.08%)

Global Indices

Nasdaq

52,820.00 -615.25
(-1.15%)

Dow Jones

7,695.68 -43.92
(-0.57%)

Hang Seng

65,089.68 -179.65
(-0.28%)

Nikkei 225

10,664.98 -146.68
(-1.36%)

Forex

USD-INR

94.51 0.08
(0.08%)

EUR-INR

109.83 0.16
(0.15%)

GBP-INR

127.88 0.26
(0.20%)

JPY-INR

0.61 0.01
(0.93%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

16.59

14796.27

EPS(TTM)

Face Value()

Div & Yield %

49.8

0.6

Back

Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit

Aug 22,2026

Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.

74,764.23 -813.35 ( -1.08%)

52,820.00 -615.25 (-1.15%)

7,695.68 -43.92 (-0.57%)

65,089.68 -179.65 (-0.28%)

10,664.98 -146.68 (-1.36%)

94.51 0.08 (0.08%)

109.83 0.16 (0.15%)

127.88 0.26 (0.20%)

0.61 0.01 (0.93%)